Mazama Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Mazama Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-69,456	Closed	-$2.38M	–	217
2015 Q4	$2.38M	Buy	69,456 +43,536	+168%	+$1.36M	0.44%	66
2015 Q3	$745K	Sell	25,920 -27,107	-51%	-$1.16M	0.15%	139
2015 Q2	$2.37M	Sell	53,027 -11,762	-18%	-$443K	0.48%	71
2015 Q1	$2.24M	Buy	64,789 +62,826	+3,201%	+$1.71M	0.46%	66
2014 Q4	$54K	Buy	+1,963	New	+$47.6K	0.01%	230

Other funds holding DPLO

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Mazama Capital Management's DPLO Position: Q1 2016 in Review

Mazama Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2016, closing a stake of 69,456 shares — an estimated $2.38M sold.

Mazama Capital Management first reported a position in DPLO in Q4 2014 and held it in 5 quarters. The position peaked at $2.38M in Q4 2015. 160 funds tracked by Wall St. Rank hold DPLO as of Q1 2016.

Mazama Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2016 after selling out during the quarter.
Mazama Capital Management sold 69,456 DIPLOMAT PHARMACY, INC. shares in Q1 2016, an estimated $2.38M.
Mazama Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 5 quarters.
Mazama Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $2.38M in Q4 2015.
160 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2016.

Based on Mazama Capital Management's 13F filing for Q1 2016.